Media & Resources

MedImmune is the newest member of the Human Vaccines Project, which will help to accelerate the research and development of vaccines and immunotherapies for infectious disease and cancer.

NEW YORK – AUGUST 12, 2015 – The Board of Directors of the International AIDS Vaccine Initiative (IAVI) announced today that Mark Feinberg, MD, PhD, has been appointed IAVI’s new President and CEO, effective 8 September 2015. “Mark brings a wealth of relevant experience and the passion to lead IAVI through the next chapter of…

NEW YORK – The International AIDS Vaccine Initiative (IAVI) has made significant contributions to strengthening health research systems in East Africa, according to a study published by RAND Europe on 30 July. In order to develop effective AIDS vaccines for use throughout the world, it is essential to build partnerships and bolster capacity to conduct…

NEW YORK – The latest data from the HIV Vaccines and Microbicides Resource Tracking Working Group highlights concerning trends in funding for vaccine-related research and development. Among the report’s key findings: There’s a flat trend in AIDS vaccine R&D investment. While funding for crucial HIV treatment and prevention programs in low- and middle-income countries is…

Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) are pleased to announce that VUMC has become the Project’s first scientific hub. Incubated by IAVI, the Human Vaccines Project is a new public-private partnership that brings together leading academic research centers, industry, governments and nonprofits to accelerate the…

The International AIDS Vaccine Initiative (IAVI) applauds the UNAIDS-Lancet Commission’s call for the world to urgently step up efforts to expand access to HIV/AIDS treatment and to “get serious” about prevention, including supporting development of an HIV vaccine. Without these stepped-up efforts, the world will “risk the epidemic rebounding” and “face more HIV infections and…

New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows that an experimental vaccine candidate can stimulate the immune system to block HIV infection in mice. The new candidate has the potential to inform immunization strategies against AIDS for humans. The effort to develop…

On the occasion of the visit of Dutch Prime Minister, Mr. Mark Rutte, to New Delhi, the two countries plan to expand their existing cooperation in the area of large scale patient cohorts with a Joint Cohort study on HIV patients in India. It is proposed that the joint cohort study will be executed by…